Permeability properties of tumor surrogate blood vessels induced by VEGF-A

被引:94
作者
Nagy, Janice A.
Feng, Dian
Vasile, Eliza
Wong, Wendy H.
Shih, Shu-Ching
Dvorak, Ann M.
Dvorak, Harold F.
机构
[1] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
VEGF-A; permeability; mother vessels; GMP; VVOs; vascular malformations;
D O I
10.1038/labinvest.3700436
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Malignant tumors generate new blood vessels by secreting growth factors, particularly members of the vascular permeability factor/vascular endothelial growth factor ( VPF/VEGF) family. Overall, the new blood vessels that form are hyperpermeable to plasma proteins, a property that is thought to be important for generating new stroma. However, tumor blood vessels are structurally heterogeneous and include microvessels of at least the following distinct types: mother vessels ( MV), glomeruloid microvascular proliferations ( GMP), arterio-venous-like vascular malformations and capillaries. Our goal was to determine whether macromolecular tracers leaked from all or from only a subset of these vessel types and to elucidate the extravasation pathways. As blood vessels are only a minor component of tumors, and therefore, difficult to study in situ, we used an adenoviral vector to express VEGF-A(164), the most important member of the VPF/VEGF family, in mouse tissues. So expressed, VEGF-A(164) induces large numbers of surrogate vessels of each type found in tumors in a highly reproducible manner. Overall permeability to plasma proteins was assessed qualitatively with Evan's blue dye and quantitatively with a dual tracer method employing radioactive albumin. Leaky vessels were identified by confocal microscopy ( FITC-dextran) and by electron microscopy ( ferritin). MV, and to a lesser extent GMP, were found to be hyperpermeable but capillaries and vascular malformations were not. Ferritin extravasated primarily by two trans-cellular routes, vesiculo-vacuolar organelles ( VVOs) and fenestrae. This occurred despite a considerable reduction in VVO frequency as VVO membranes translocated to the plasma membrane during MV formation. However, reduction in the number and complexity of VVOs was offset by extensive endothelial cell thinning and a greatly shortened extravasation pathway. Extrapolating these findings to tumors predicts that only a subset of tumor vessels, MV and GMP, is hyperpermeable, and that measures of overall vessel permeability greatly underestimate the permeability of individual MV and GMP.
引用
收藏
页码:767 / 780
页数:14
相关论文
共 49 条
  • [1] Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR
    Aerts, JL
    Gonzales, MI
    Topalian, SL
    [J]. BIOTECHNIQUES, 2004, 36 (01) : 84 - +
  • [2] EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) BY EPIDERMAL-KERATINOCYTES DURING WOUND-HEALING
    BROWN, LF
    YEO, KT
    BERSE, B
    YEO, TK
    SENGER, DR
    DVORAK, HF
    VANDEWATER, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) : 1375 - 1379
  • [3] BROWN LF, 1997, EXS, V79, P233, DOI DOI 10.1007/978-3-0348-9006-9_10
  • [4] Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
    Carmeliet, P
    Moons, L
    Luttun, A
    Vincenti, V
    Compernolle, V
    De Mol, M
    Wu, Y
    Bon, F
    Devy, L
    Beck, H
    Scholz, D
    Acker, T
    DiPalma, T
    Dewerchin, M
    Noel, A
    Stalmans, I
    Barra, A
    Blacher, S
    Vandendriessche, T
    Ponten, A
    Eriksson, U
    Plate, KH
    Foidart, JM
    Schaper, W
    Charnock-Jones, DS
    Hicklin, DJ
    Herbert, JM
    Collen, D
    Persico, MG
    [J]. NATURE MEDICINE, 2001, 7 (05) : 575 - 583
  • [5] OVEREXPRESSION OF VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTORS IN PSORIASIS
    DETMAR, M
    BROWN, LF
    CLAFFEY, KP
    YEE, KT
    KOCHER, O
    JACKMAN, RW
    BERSE, B
    DVORAK, HF
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) : 1141 - 1146
  • [6] Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination -: Consequences on nitric oxide production from endothelial cells
    Duval, M
    Bédard-Goulet, S
    Delisle, C
    Gratton, JP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (22) : 20091 - 20097
  • [7] PROCEDURAL GUIDE TO SPECIMEN HANDLING FOR THE ULTRASTRUCTURAL PATHOLOGY SERVICE LABORATORY
    DVORAK, AM
    [J]. JOURNAL OF ELECTRON MICROSCOPY TECHNIQUE, 1987, 6 (03): : 255 - 301
  • [8] The vesiculo-vacuolar organelle (VVO): A distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation
    Dvorak, AM
    Kohn, S
    Morgan, ES
    Fox, P
    Nagy, JA
    Dvorak, HF
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (01) : 100 - 115
  • [9] DVORAK H, 2006, IN PRESS ENDOTHELIUM
  • [10] Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97